Organigram Global Sets May 12 Date to Report Q2 2026 Results
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Organigram Global ( (TSE:OGI) ) has issued an announcement.
Organigram Global Inc., Canada’s largest cannabis company by market share, will report financial results for its second quarter of fiscal 2026, covering the period ended March 31, 2026, on Tuesday, May 12, 2026, before markets open. The company will host a same-day conference call and webcast and make a replay available for 90 days, underscoring its ongoing efforts to engage investors and provide visibility into its operating performance.
The planned disclosure comes as Organigram continues to expand across dried flower, edibles, extracts and cannabinoid beverages in Canada and the U.S. By pairing multi-facility production capabilities with a broad brand portfolio, the earnings update is expected to offer stakeholders further insight into how the company is leveraging its scale and infrastructure in a competitive, tightly regulated cannabis market.
The most recent analyst rating on (TSE:OGI) stock is a Buy with a C$3.50 price target. To see the full list of analyst forecasts on Organigram Global stock, see the TSE:OGI Stock Forecast page.
Spark’s Take on OGI Stock
According to Spark, TipRanks’ AI Analyst, OGI is a Neutral.
The score is held back most by weak underlying profitability/cash flow and bearish technicals (below key moving averages with negative MACD). Offsetting these are a strong low-leverage balance sheet, a low P/E valuation, and a generally positive earnings call with reiterated full-year guidance and improving operational metrics.
To see Spark’s full report on OGI stock, click here.
More about Organigram Global
Organigram Global Inc. is a Canada-based cannabis producer listed on the NASDAQ Global Select Market and TSX, with wholly owned subsidiaries including Organigram Inc., a licensed cultivator and processor. The company focuses on high-quality adult-use cannabis and cannabinoid beverages in Canada and the U.S., and markets brands such as Edison, SHRED, Big Bag O’ Buds, Monjour, Tremblant, Collective Project, Trailblazer, BOXHOT and DEBUNK.
Organigram operates cultivation and processing facilities in Moncton, New Brunswick and Lac Supérieur, Quebec, as well as an edibles plant in Winnipeg, Manitoba. It also runs two cannabis processing sites in Southwestern Ontario, with Aylmer dedicated to extraction and infused products, and London set up for labelling, packaging and national fulfillment under Health Canada’s Cannabis Act framework.
Average Trading Volume: 218,134
Technical Sentiment Signal: Sell
Current Market Cap: C$257.7M
For detailed information about OGI stock, go to TipRanks’ Stock Analysis page.
